The difficult diagnosis of pulmonary vascular disease in heart failure

European Respiratory Journal

Volumn 48, Issue 2, 2016, Pages 308-310

  Naeije, Robert ^a   Hemnes, Anna Ryan ^b  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE RESPIRATORY FAILURE; AIRWAY PRESSURE; AORTA VALVE DISEASE; CARDIOPULMONARY HEMODYNAMICS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HIGH RISK POPULATION; HUMAN; LUNG ARTERY PRESSURE; LUNG CIRCULATION; LUNG VASCULAR RESISTANCE; LUNG WEDGE PRESSURE; MITRAL VALVE DISEASE; MULTICENTER STUDY (TOPIC); PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; PULMONARY VENOUS PRESSURE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REFERENCE VALUE; REVIEW; SURVIVAL RATE; HEART FAILURE; LUNG DISEASE; VASCULAR DISEASE; VASCULAR RESISTANCE;

HEART FAILURE; HUMANS; LUNG DISEASES; PULMONARY CIRCULATION; VASCULAR DISEASES; VASCULAR RESISTANCE;

EID: 84979997711     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/13993003.00789-2016     Document Type: Review

References (30)

1. Gerges M, Gerges C, Lang IM. How to define pulmonary hypertension due to left heart disease. Eur Respir J 2016; 48: 553-555.
2. Vachiéry JL, Adir Y, Barber? JA, et al. Pulmonary hypertension due to left heart diseases. J Am Coll Cardiol 2013; 62: Suppl. 25, D100-D108.
3. Rosenkranz S, Gibbs JS, Wachter R, et al. Left ventricular heart failure and pulmonary hypertension. Eur Heart J 2016; 37: 942-954.
4. Galiè N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2015; 46: 903-975.
5. Gerges C, Gerges M, Lang MB, et al. Diastolic pulmonary vascular pressure gradient: a predictor of prognosis in "out-of-proportion" pulmonary hypertension. Chest 2013; 143: 758-766.
6. Gerges M, Gerges C, Pistritto AM, et al. Pulmonary hypertension in heart failure. Epidemiology, right ventricular function, and survival. Am J Respir Crit Care Med 2015; 192: 1234-1246.
7. Cournand A, Bloomfield RA, Lauson HD. Double lumen catheter for intravenous and intracardiac blood sampling and pressure recording. Proc Soc Exp Biol Med 1945; 60: 73-75.
8. Parker F Jr, Weiss S. The nature and significance of the structural changes in the lungs in mitral stenosis. Am J Pathol 1936; 12: 573-598.
9. Wood P. Pulmonary hypertension with special reference to the vasoconstrictive factor. Br Heart J 1958; 20: 557-570.
10. Murali S, Kormos RL, Uretsky BF, et al. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation: the Pittsburgh experience. Am Heart J 1993; 126: 896-904.
11. Fang JC, DeMarco T, Givertz MM, et al. World Health Organization Pulmonary Hypertension Group 2: Pulmonary hypertension due to left heart disease in the adult -a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2012; 31: 913-933.
12. Dalen JE, Dexter L, Ockene IS, et al. Precapillary pulmonary hypertension; its relationship to pulmonary venous hypertension. Trans Am Clin Climatol Assoc 1975; 86: 207-218.
13. Guazzi M, Borlaug BA. Pulmonary hypertension due to left heart disease. Circulation 2012; 126: 975-990.
14. Naeije R, Vachiery JL, Yerly P, et al. The transpulmonary pressure gradient for the diagnosis of pulmonary vascular disease. Eur Respir J 2013; 41: 217-223.
15. Stevens PM. Assessment of acute respiratory failure: cardiac versus pulmonary causes. Chest 1975; 67: 1-2.
16. Harvey RM, Enson Y, Ferrer MI. A reconsideration of the origins of pulmonary hypertension. Chest 1971; 59: 82-94.
17. Halpern SD, Taichman DB. Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure. Chest 2009; 136: 37-43.
18. Tampakakis E, Leary PJ, Selby VN, et al. The diastolic pulmonary gradient does not predict survival in patients with pulmonary hypertension due to left heart disease. JACC Heart Fail 2015; 3: 9-16.
19. Gerges C, Gerges M, Lang IM. Characterization of pulmonary hypertension in heart failure using the diastolic pressure gradient: the conundrum of high and low diastolic pulmonary gradient. JACC Heart Fail 2015; 3: 424-425.
20. Tedford RJ, Beaty CA, Mathai SC, et al. Prognostic value of the pre-transplant diastolic pulmonary artery pressure-to-pulmonary capillary wedge pressure gradient in cardiac transplant recipients with pulmonary hypertension. J Heart Lung Transplant 2014; 33: 289-297.
21. Chatterjee NA, Lewis GD. Characterization of pulmonary hypertension in heart failure using the diastolic pressure gradient: limitations of a solitary measurement. JACC Heart Fail 2015; 3: 17-21.
22. Brittain EL, Assad TR, Hemnes AR, et al. The diastolic pressure gradient does not -and should not -predict outcomes. JACC Heart Fail 2015; 3: 845.
23. Naeije R. Measurement to predict survival: the case of diastolic pulmonary gradient. JACC Heart Fail 2015; 3: 425.
24. Dragu R, Rispler S, Habib M, et al. Pulmonary arterial capacitance in patients with heart failure and reactive pulmonary hypertension. Eur J Heart Fail 2015; 17: 74-80.
25. Ibe T, Wada H, Sakakura K, et al. Pulmonary hypertension due to left heart disease: the prognostic implications of diastolic pulmonary vascular pressure gradient. J Cardiol 2016; 67: 555-559.
26. O'Sullivan CJ, Wenaweser P, Ceylan O, et al. Effect of pulmonary hypertension hemodynamic presentation on clinical outcomes in patients with severe symptomatic aortic valve stenosis undergoing transcatheter aortic valve implantation: insights from the new proposed pulmonary hypertension classification. Circ Cardiovasc Interv 2015; 8: e002358.
27. Nichols EL, Rezaee ME, Brown JR. One-year survival in heart failure patients with preserved ejection fraction and isolated post-capillary or combined post-and pre-capillary pulmonary hypertension. Circulation 2015; 132: Suppl. 3, A14302.
28. Vanderpool RR, Naeije R. Progress in pulmonary hypertension with left heart failure. Beyond new definitions and acronyms. Am J Respir Crit Care Med 2015; 192: 1152-1154.
29. Zener JC, Hancock EW, Shumway NE, et al. Regression of extreme pulmonary hypertension after mitral valve surgery. Am J Cardiol 1972; 30: 820-826.
30. Guazzi M, Vicenzi M, Arena R, et al. Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study. Circulation 2011; 124: 164-174.